1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Cunningham D, Okines AF and Ashley S:
Capecitabine and oxaliplatin for advanced esophagogastric cancer. N
Engl J Med. 362:858–859. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Nagini S: Carcinoma of the stomach: A
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li R, Zhu H and Luo Y: Understanding the
functions of long non-coding RNAs through their higher-order
structures. Int J Mol Sci. 17:pii: E7022016. View Article : Google Scholar
|
9
|
Qi P, Zhou XY and Du X: Circulating long
non-coding RNAs in cancer: Current status and future perspectives.
Mol Cancer. 15:392016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Harrow J, Frankish A, Gonzalez JM,
Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa
A, Searle S, et al: GENCODE: The reference human genome annotation
for the ENCODE project. Genome Res. 22:1760–1774. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Pauli A, Rinn JL and Schier AF: Non-coding
RNAs as regulators of embryogenesis. Nat Rev Genet. 12:136–149.
2011. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Qi P, Zhou XY and Du X: Circulating long
non-coding RNAs in cancer: Current status and future perspectives.
Mol Cancer. 15:392016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Nie F, Yu X, Huang M, Wang Y, Xie M, Ma H,
Wang Z, De W and Sun M: Long noncoding RNA ZFAS1 promotes gastric
cancer cells proliferation by epigenetically repressing KLF2 and
NKD2 expression. Oncotarget. 8:38227–38238. 2017.PubMed/NCBI
|
15
|
Shao Y, Ye M, Li Q, Sun W, Ye G, Zhang X,
Yang Y, Xiao B and Guo J: LncRNA-RMRP promotes carcinogenesis by
acting as a miR-206 sponge and is used as a novel biomarker for
gastric cancer. Oncotarget. 7:37812–37824. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xue Y, Ma G, Zhang Z, Hua Q, Chu H, Tong
N, Yuan L, Qin C, Yin C, Zhang Z and Wang M: A novel antisense long
noncoding RNA regulates the expression of MDC1 in bladder cancer.
Oncotarget. 6:484–493. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yue H, Zhu J, Xie S, Li F and Xu Q:
MDC1-AS, an antisense long noncoding RNA, regulates cell
proliferation of glioma. Biomed Pharmacother. 81:203–209. 2016.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Chang AH and Parsonnet J: Role of bacteria
in oncogenesis. Clin Microbiol Rev. 23:837–857. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ruddon RW: Introduction to the molecular
biology of cancer: Translation to the clinic. Prog Mol Biol Transl
Sci. 95:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Montenegro RC, Clark PG, Howarth A, Wan X,
Ceroni A, Siejka P, Nunez-Alonso GA, Monteiro O, Roger C, Gamble V,
et al: BET inhibition as a new strategy for the treatment of
gastric cancer. Oncotarget. 7:43997–44012. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Stewart GS, Wang B, Bignell CR, Taylor AM
and Elledge SJ: MDC1 is a mediator of the mammalian DNA damage
checkpoint. Nature. 421:961–966. 2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Nakanishi M, Ozaki T, Yamamoto H, Hanamoto
T, Kikuchi H, Furuya K, Asaka M, Delia D and Nakagawara A:
NFBD1/MDC1 associates with p53 and regulates its function at the
crossroad between cell survival and death in response to DNA
damage. J Biol Chem. 282:22993–23004. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Morris KV and Vogt PK: Long antisense
non-coding RNAs and their role in transcription and oncogenesis.
Cell Cycle. 9:2544–2547. 2010. View Article : Google Scholar : PubMed/NCBI
|